Evidence map›Paper›PMID 27644937›Full record

ReviewPharmaceutical research2016

Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.

Anand A Joshi, Soniya S Vaidya, Marie V St-Pierre, Andrei M Mikheev, Kelly E Desino, Abner N Nyandege, Kenneth L Audus, Jashvant D Unadkat, Phillip M Gerk

Open access · greenAbstract readReview
In one paragraph

Review in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Article
  8. MiRNAs: main players of cancer drug resistance target ABC transporters.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Placenta: an old organ with new functions.Frontiers in immunology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Anand A JoshiDepartment of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, 23298-0533, USA.
Soniya S VaidyaDepartment of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, 23298-0533, USA.
Marie V St-PierreDepartment of Clinical Pharmacology and Toxicology, University of Zurich Hospital, Zurich, Switzerland.
Andrei M MikheevDepartment of Pharmaceutics, University of Washington School of Pharmacy, Seattle, Washington, USA.
Kelly E DesinoDepartment of Pharmaceutical Chemistry, University of Kansas School of Pharmacy, Lawrence, Kansas, USA.
Abner N NyandegeDepartment of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, 23298-0533, USA.
Kenneth L AudusDepartment of Pharmaceutical Chemistry, University of Kansas School of Pharmacy, Lawrence, Kansas, USA.
Jashvant D UnadkatDepartment of Pharmaceutics, University of Washington School of Pharmacy, Seattle, Washington, USA.
Phillip M GerkDepartment of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, 23298-0533, USA. pmgerk@vcu.edu.
Virginia Commonwealth University · USUniversity of Washington · USAbbVie (United States) · USUniversity of Kansas · USUniversity of Zurich · CH

Funding

Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo StudiesP01DA032507 · NIDA · UNIVERSITY OF WASHINGTON · PI UNADKAT, JASHVANT D · 2013 to 2023
$12.4M
Using resistance training to reduce metabolic and cardiovascular disease risk inP60MD002254 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GORAN, MICHAEL ISAAC · 2007 to 2011
$8.1M
NIDA NIH HHS P01 DA032507NIMHD NIH HHS P60 MD002254
6 · The paper itself

Abstract

The human placenta fulfills a variety of essential functions during prenatal life. Several ABC transporters are expressed in the human placenta, where they play a role in the transport of endogenous compounds and may protect the fetus from exogenous compounds such as therapeutic agents, drugs of abuse, and other xenobiotics. To date, considerable progress has been made toward understanding ABC transporters in the placenta. Recent studies on the expression and functional activities are discussed. This review discusses the placental expression and functional roles of several members of ABC transporter subfamilies B, C, and G including MDR1/P-glycoprotein, the MRPs, and BCRP, respectively. Since placental ABC transporters modulate fetal exposure to various compounds, an understanding of their functional and regulatory mechanisms will lead to more optimal medication use when necessary in pregnancy.

Indexed as

AnimalsATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BBiological TransportCytokinesFemaleHormonesHumansMaternal-Fetal ExchangePharmaceutical PreparationsPlacentaPolymorphism, GeneticPregnancyXenobioticsATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BCytokinesHormonesPharmaceutical PreparationsXenobioticsbreast cancer resistance proteindrug transportmultidrug resistance-associated proteinP-glycoproteinplacentaregulation of expression

Identifiers

PMID27644937
PMCPMC5384842
OpenAlexW2522497821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.